CoChat
Sign Up
Cited by 276Hepatitis B Virus StudiesHepatitis C virus researchCervical Cancer and HPV Research

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.

Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma

Kew, M.C.·2010·Pathologie Biologie
DOI 10.1016/j.patbio.2010.01.005
Open this paper in CoChat — free account

Abstract

Approximately 360 million people worldwide are chronically infected with hepatitis B virus (HBV) and are at high risk of developing hepatocellular carcinoma (HCC). Chronic HBV infection is the most prevalent cause of this tumour, accounting for 55% of global cases, and 89% of those in endemic regions for HBV infection. Relative risks for developing HCC in the presence of chronic HBV infection may be as high as 49 in case-control studies, and 98 in cohort studies. HCC is the sixth most common cancer in the world today, with approximately 630,000 new cases occurring each year. It ranks third in annual cancer mortality rates. Approximately 80% of HCCs occur in developing countries where HBV infection is endemic, with the highest incidences being in the Asia-Pacific region, and sub-Saharan Africa. In the chronic carriers of the virus who are at greatest risk of developing HCC, the infection is acquired at birth or in the early months or years of life, either perinatally or horizontally, and frequently becomes chronic. The risks are greater in males, and older individuals, and are increased by co-exposure to aflatoxin B(1), the presence of cirrhosis, obesity, or diabetes mellitus, and possibly co-infection with hepatitis C virus. Viral factors that influence the risk of HCC are high viral load, the presence of certain mutations, and genotypes. Although the incidence of chronic HBV infection is beginning to decrease as a result of the universal infant immunization programme, HBV-induced HCC incidence is projected to increase for at least another two decades.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.patbio.2010.01.005

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 63 references

1 of the 63 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. Robinson, 2005, The New Zealand hepatitis B screening programme: screening coverage and prevalence of hepatitis B infection, N Z Med J, 118, U1345
  2. Chia, 1996, Singapore cancer registry report No. 4. Trends in cancer incidence in Singapore 1968–1992, Singapore Cancer Rep, 4, 86
  3. 1994, Hepatitis viruses, vol. 59, 66
  4. Kew, 1998, Hepatitis C virus and hepatocellular carcinoma in developing and developed countries, Vir Hepatit Rev, 4, 259

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Kew, M. C.
Affiliations
University of Cape Town (ZA)
Corresponding author
Kew, M.C.
Venue
Pathologie Biologie
Publisher
Elsevier BV
Published
2010-08
Volume
58
Issue
4
Pages
273-277
ISSN
0369-8114 (ISSN-L)
DOI
10.1016/j.patbio.2010.01.005
OpenAlex
W1995958786
Cited by
275
References
63
Citations by year
2026: 6 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 11 · 2021: 16 · 2020: 13 · 2019: 26 · 2018: 12 · 2017: 21 · 2016: 22 · 2015: 28 · 2014: 36 · 2013: 27 · 2012: 25
FWCI
15.59
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Pathologie Biologie (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords
chronic hepatitis B, hepatocellular carcinoma, HBV genotypes, HBV mutations, aflatoxin B1, liver cirrhosis, hepatitis C coinfection, cancer incidence and mortality, risk factors, developing countries
MeSH terms
Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Risk, Sex Factors, Aflatoxin B1, Hepatitis B Vaccines, Endemic Diseases, Hepatitis B, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review